Antibiotic resistance mechanisms of Escherichia coli isolates from urinary specimens;Korean Source

Korean Journal of Laboratory Medicine

Volumn 29, Issue 1, 2009, Pages 17-24

  Song, Sungwook ^a   Lee, Eun Young ^a   Koh, Eun Mi ^a   Ha, Ho Sung ^b   Jeong, Ho Joong ^b   Bae, Il Kwon ^b   Jeong, Seok Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kosin University College of Medicine   (South Korea)

Author keywords

Escherichia coli; Extended spectrum lactamases (ESBL); Phylogenetic group

Indexed keywords

16S RRNA - M7G METHYLTRANSFERASE; 16S RRNA M7G METHYLTRANSFERASE; AMPC BETA LACTAMASES; AMPC BETA-LACTAMASES; BACTERIAL PROTEIN; BETA LACTAMASE; CIPROFLOXACIN; METHYLTRANSFERASE;

ARTICLE; BACTERIURIA; BIOSYNTHESIS; DISK DIFFUSION; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; PHYLOGENY;

BACTERIAL PROTEINS; BACTERIURIA; BETA-LACTAMASES; CIPROFLOXACIN; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; HUMANS; METHYLTRANSFERASES; PHYLOGENY;

EID: 67249109502     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2009.29.1.17     Document Type: Article

References (31)

1. Piatti G, Mannini A, Balistreri M, Schito AM. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol 2008;46: 480-7.
2. Bonnet R. Growing group of extended-spectrum (-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;48:1-14.
3. Kim J, Lim YM, Jeong YS, Seol SY. Occurrence of CTX-M-3, CTXM-15, CTX-M-14, and CTX-M-9 extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Korea. Antimicrob Agents Chemother 2005;49:1572-5.
4. Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-Mtype extended-spectrum β-lactamases. Clin Microbiol Infect 2008; 14(S):33-41.
5. Bae IK, Lee YN, Jeong SH, Lee K, Yong D, Lee J, et al. Emergence of CTX-M-12, PER-1 and OXA-30 β-lactamase-producing Klebsiella pneumoniae. Korean J Clin Microbiol 2006;9:102-9. (Korean Source. CTX-M-12, PER-1 Korean Source OXA-30 (-Lactamase Korean Source Klebsiella pneumoniae Korean Source 2006;9:102-9.)
6. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002;46:1-11.
7. Lee K, Lee M, Shin JH, Lee MH, Kang SH, Park AJ, et al. Prevalence of plasmid-mediated AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microb Drug Resist 2006;12:44-9.
8. Hooper DC. Mechanisms of fluoroquinolone resistance. Drug Resist Updat 1999;2:38-55.
9. Herzer PJ, Inouye S, Inouye M, Whittam TS. Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol 1990;172:6175-81.
10. Jeong SH, Bae IK, Lee JH, Sohn SG, Kang GH, Jeon GJ, et al. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. J Clin Microbiol 2004;42:2902-6.
11. Jeong JY, Yoon HJ, Kim ES, Lee Y, Choi SH, Kim NJ, et al. Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob Agents Chemother 2005;49:2522-4.
12. Jeong SH, Bae IK, Kwon SB, Lee JH, Jung HI, Song JS, et al. Investigation of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea. Lett Appl Microbiol 2004;39:41-7.
13. Magnet S and Blanchard JS. Molecular insights into aminoglycoside action and resistance. Chem Rev 2005;105:477-98.
14. Doi Y and Arakawa Y. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 2007; 45:88-94.
15. Baudry PJ, Nichol K, DeCorby M, Mataseje L, Mulvey MR, Hoban DJ, et al. Comparison of antimicrobial resistance profiles among extended-spectrum β-lactamase-producing and acquired AmpC β-lactamase-producing Escherichia coli isolates from Canadian intensive care units. Antimicrob Agents Chemother 2008;52:1846-9.
16. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement: Approved Standard M100-S17, Wayne, PA: Clinical Laboratory Standards Institute, 2007.
17. Sambrook J, Fritsch EF, et al. eds. Molecular cloning: a laboratory manual. 2nd ed. NY: Cold Spring Harbor Laboratory Press, 1989.
18. Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, et al. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 2005;56:698-702.
19. Song W, Kim JS, Kim HS, Yong D, Jeong SH, Park MJ, et al. Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn Microbiol Infect Dis 2006;55:219-24.
20. Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007;60:394-7.
21. Fihman V, Lartigue MF, Jacquier H, Meunier F, Schnepf N, Raskine L, et al. Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital. J Infect 2008;56:454-9.
22. Fritsche TR, Castanheira M, Miller GH, Jones RN, Armstrong ES. Detection of methyltransferases conferring high-level resistance to aminoglycosides in Enterobacteriaceae from Europe, North America, and Latin America. Antimicrob Agents Chemother 2008;52:1843-5.
23. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555-8.
24. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007;6:4-10.
25. Mazzei T, Cassetta MI, Fallani S, Arrigucci S, Novelli A. Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections. Int J Antimicrob Agents 2006;28(S):S35-41.
26. Ko CS, Sung JY, Koo SH, Kwon GC, Shin SY, Park JW. Prevalence of Extended-Spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon. Korean J Lab Med 2007;27:344-50. (Korean Source Escherichia coli Korean Source Klebsiella pneumoniae Korean Source Extended-spectrum β-lactamase Korean Source 2007;27:344-50.)
27. Hong SG, Kim S, Jeong SH, Chang CL, Cho SR, Ahn JY, et al. Prevalence and diversity of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Korea. Korean J Clin Microbiol 2003;6:149-55. (Korean Source Extended-Spectrum β-Lactamase Korean Source Escherichia coli Korean Source Klebsiella pneumoniae Korean Source 2003;6:149-55.)
28. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52-9.
29. Johnson JR, Delavari P, Kuskowski M, Stell AL. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis 2001;183:78-88.
30. Johnson JR, Kuskowski MA, Owens K, Gajewski A, Winokur PL. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J Infect Dis 2003;188:759-68.
31. Pitout JD, Laupland KB, Church DL, Menard ML, Johnson JR. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum β-lactamases. Antimicrob Agents Chemother 2005;49:4667-70.